When you are dealing with rare events in clinical trials, even a handful of additional cases can produce alarming-looking relative risk numbers
Over time, obese patients lose roughly 12% of their body weight on Wegovy (semaglutide) and about 18% on Zepbound (tirzepatide, which targets GLP-1 and another gut hormone, GIP.) Diana Thiara, MD, medical director of the UCSF Weight Management Program, says the results can be amazing and life-changing for people with obesity, a condition linked to a host of health risks
Studies have disclosed that low glutathione levels increase oxidative stress on cells throughout the body, which may increase the risk of developing cancer
Clinical check-ins and symptom logs allowed clinicians to slow escalation rather than stop therapy, preserving continuity and reducing avoidable discontinuations
Visit Axon Integrative Health in Denver to explore the power of Glutathione IV therapy and experience the numerous advantages it can offer
However, the data remains inconclusive